CN101711854B - Traditional Chinese medicine for treating cardiovascular and cerebrovascular diseases - Google Patents
Traditional Chinese medicine for treating cardiovascular and cerebrovascular diseases Download PDFInfo
- Publication number
- CN101711854B CN101711854B CN200910312176XA CN200910312176A CN101711854B CN 101711854 B CN101711854 B CN 101711854B CN 200910312176X A CN200910312176X A CN 200910312176XA CN 200910312176 A CN200910312176 A CN 200910312176A CN 101711854 B CN101711854 B CN 101711854B
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicine
- cardiovascular
- radix
- traditional chinese
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a traditional Chinese medicine for treating cardiovascular and cerebrovascular diseases, which is mainly prepared from the following components in parts by weight: 20-50 parts of leech, 20-30 parts of earthworm, 25-40 parts of chicken's gizzard-membrane, 30-40 parts of rhizoma ligustici wallichii, 30-40 parts of radix salviae miltiorrhizae, 20-30 parts of radix notoginseng, 15-30 parts of safflower, 15-30 parts of Japanese sweetflag, 10-20 parts of TurmericRoot-tuber, 20-30 parts of senega and 10-20 parts of Chinese Ligusticum Rhizome. The traditional Chinese medicine aims at the cardiovascular and cerebrovascular diseases, is mainly used for treating coronary heart diseases, myocardial infarction, cerebral thrombus, cerebral infarction, hemiplegia, aphasia and apoplexy sequelae caused by the stasis of the veins of the heart and the brain and arteriosclerosis and can also relieve an adverse reaction occurring in the recovery period of cerebral hemorrhage. The clinical application of many years proves that the cure rate of the traditional Chinese medicine for treating the cardiovascular and cerebrovascular diseases reaches 63%, the total effective rate reaches 95%, and the traditional Chinese medicine has obvious effect and better popularization and application prospect.
Description
Technical field
The present invention relates to a kind of Chinese medicine for the treatment of cardiovascular and cerebrovascular disease, belong to technical field of Chinese medicines.
Background technology
Cardiovascular and cerebrovascular disease comprises hypertension, arteriosclerosis, cerebral thrombosis, cerebral infarction, coronary heart disease, angina pectoris, myocardial infarction etc.Its pathogenic factor is that coronary artery or cerebrovascular atherosclerosis make angiemphraxis, cause cardiac muscle or cerebrum ischemia, anoxia, thereby the above-mentioned various diseases that cause, and the complication that causes thus, as apoplexy etc., have a strong impact on the healthy of people, hemiplegia can appear in severe patient, aphasia, consequences such as cerebral hemorrhage, in addition dead.The main method of treatment cardiovascular and cerebrovascular disease is for taking Western medicine at present, but the patient use behind the Western medicine in the recent period and long-term effect undesirable, just reach blood vessel dilating and improved the temporary curative effect of circulation, mobile the dissolving of speckle or thrombosis etc. that come off in the blood vessel do not had too big effect, be difficult to thrombolytic; And often use this type of Western medicine to cause arterial blood tube wall flexibility decrease easily, fragility increases, cause cerebral infarction progressively to be converted into cerebral hemorrhage serious attack once more, cause more large-area infraction, be difficult to cure, and untoward reaction can appear after the small number of patients use, and side effect is bigger, and clinical cure rate is undesirable.Therefore, still there is deficiency in the medicine for the treatment of cardiovascular disease at present.
Summary of the invention
The Chinese medicine that the purpose of this invention is to provide the higher treatment cardiovascular and cerebrovascular disease of a kind of total effective rate.
The technical scheme that Chinese medicine of the present invention adopted based on motherland's medical science to cardiovascular and cerebrovascular disease and the pathogenetic understanding of complication thereof, understand and the Therapeutic Principle, achievement with reference to modern pharmacological research, sum up the clinical experience of treatment cardiovascular and cerebrovascular disease for many years, in the wide medical treasure-house of motherland, filter out ten Chinese herbal medicine simply, make the Chinese medicine of treatment cardiovascular and cerebrovascular disease.
The Chinese medicine that the present invention treats cardiovascular and cerebrovascular disease is to be made by the component of following weight portion: 20～50 parts of Hirudos, 20～30 parts of Pheretimas, 25～40 parts of Endothelium Corneum Gigeriae Galli, 30～40 parts of Rhizoma Chuanxiongs, 30～40 parts of Radix Salviae Miltiorrhizaes, 20～30 parts of Radix Notoginseng, 15～30 parts on Flos Carthami, 15～30 parts of Rhizoma Acori Graminei, 10～20 parts of Radix Curcumaes, 20～30 parts of Radix Polygalaes, 10～20 parts of Rhizoma Ligusticis.
Described Chinese medicinal components is preferably: 30～40 parts of Hirudos, 22～27 parts of Pheretimas, 30～35 parts of Endothelium Corneum Gigeriae Galli, 33～38 parts of Rhizoma Chuanxiongs, 32～38 parts of Radix Salviae Miltiorrhizaes, 22～28 parts of Radix Notoginseng, 20～25 parts on Flos Carthami, 20～26 parts of Rhizoma Acori Graminei, 13～18 parts of Radix Curcumaes, 22～27 parts of Radix Polygalaes, 13～17 parts of Rhizoma Ligusticis.
The dosage form that described Chinese medicine adopted is pharmaceutically acceptable dosage form.
The present invention treats the Chinese medicine of cardiovascular and cerebrovascular disease and can promote blood circulation by blood stasis dispersing and fresh blood promoting, the expelling wind to relieve convulsion collateral dredging.Hirudo wherein, removing blood stasis stimulates the menstrual flow; Pheretima, the heat clearing away arresting convulsion, collateral dredging is relievingd asthma; Rhizoma Chuanxiong, Radix Salviae Miltiorrhizae, blood-activating and qi-promoting, wind-expelling pain-stopping; Radix Notoginseng, Flos Carthami, dissipating blood stasis hemostasis, subduing swelling and relieving pain; Rhizoma Acori Graminei, Radix Polygalae, the Fructus Alpiniae Oxyphyllae of calming the nerves, the eliminating phlegm of having one's ideas straightened out, regulating the spleen and stomach sedate; Radix Curcumae, regulating qi to disperse stagnation, heart fire-clearing upset-relieving, promoting the function of the gallbladder to alleviate jaundice; Endothelium Corneum Gigeriae Galli, the refreshment of having one's ideas straightened out; Rhizoma Ligustici, expelling wind and cold, removing damp and stopping pain.Rhizoma Ligustici is joined Radix Polygalae and then draws the through heart and brain sufferer place of all medicines, at cardiovascular and cerebrovascular disease, eliminates thrombosis in the cardiovascular and cerebrovascular vessel or the speckle that comes off, and fundamentally treats cardiovascular and cerebrovascular disease; And Chinese medicine of the present invention can also be to having good alleviation and therapeutical effect by the cardiovascular and cerebrovascular vessel stasis of blood stagnates or arteriosclerosis caused symptom or apoplexy sequela.
Chinese medicine of the present invention is at cardiovascular and cerebrovascular disease, be mainly used in treatment by the heart and brain venation stasis of blood stagnates, arteriosclerosis causes coronary heart disease, myocardial infarction, cerebral thrombosis, cerebral infarction, hemiplegia, aphasia and apoplexy sequela, can also alleviate the untoward reaction that cerebral hemorrhage occurred between convalescent period.The medical material that Chinese medicine of the present invention adopted is ordinary, and the property of medicine is gentle, and safety non-toxic has significant curative effect to cardiovascular and cerebrovascular disease.Chinese medicine of the present invention is treated patient's 526 examples altogether in clinical practice for many years, coronary heart disease 122 examples wherein, cerebral infarction 308 examples, hemorrhagic apoplexy 96 examples.Total cure rate 63%, total effective rate 95%, effect is remarkable.
The present invention treats the Chinese medicine of cardiovascular and cerebrovascular disease, selects ten Chinese herbal medicine simply for use, drying, pulverizing respectively, with ten simply Chinese herbal medicine be mixed in proportion, facing-up evenly, pack into, make capsule, every capsules contains Chinese medicine 0.4 gram.The instructions of taking of Chinese medicine of the present invention is: oral every day 3 times, and each 3-4 grain, eliminating cold for resuscitation water send down, and the intake of every day is 9～12.Chinese medicine of the present invention is at cardiovascular and cerebrovascular disease, instant effect, and the curative effect height, side effect is little.In clinical practice for many years, the effective percentage of treatment is up to 95%, and drug effect is remarkable.
The specific embodiment
Embodiment 1
Chinese medicine of the present invention is to be made by the component of following weight portion: 20 parts of Hirudos, 30 parts of Pheretimas, 25 parts of Endothelium Corneum Gigeriae Galli, 40 parts of Rhizoma Chuanxiongs, 35 parts of Radix Salviae Miltiorrhizaes, 20 parts of Radix Notoginseng, 20 parts on Flos Carthami, 20 parts of Rhizoma Acori Graminei, 15 parts of Radix Curcumaes, 20 parts of Radix Polygalaes, 15 parts of Rhizoma Ligusticis.
Preparation method of Chinese medicine of the present invention: above-mentioned medical material is carried out drying, pulverizing respectively, with each medical material ammonium mixed, facing-up evenly, pack into, make capsule.
Embodiment 2
Chinese medicine of the present invention is to be made by the component of following weight portion: 30 parts of Hirudos, 20 parts of Pheretimas, 35 parts of Endothelium Corneum Gigeriae Galli, 35 parts of Rhizoma Chuanxiongs, 40 parts of Radix Salviae Miltiorrhizaes, 25 parts of Radix Notoginseng, 25 parts on Flos Carthami, 15 parts of Rhizoma Acori Graminei, 10 parts of Radix Curcumaes, 25 parts of Radix Polygalaes, 10 parts of Rhizoma Ligusticis.
Preparation method of Chinese medicine of the present invention is with embodiment 1.
Embodiment 3
Chinese medicine of the present invention is to be made by the component of following weight portion: 35 parts of Hirudos, 25 parts of Pheretimas, 40 parts of Endothelium Corneum Gigeriae Galli, 30 parts of Rhizoma Chuanxiongs, 30 parts of Radix Salviae Miltiorrhizaes, 30 parts of Radix Notoginseng, 30 parts on Flos Carthami, 26 parts of Rhizoma Acori Graminei, 20 parts of Radix Curcumaes, 30 parts of Radix Polygalaes, 20 parts of Rhizoma Ligusticis.
Preparation method of Chinese medicine of the present invention is with embodiment 1.
Embodiment 4
Chinese medicine of the present invention is to be made by the component of following weight portion: 40 parts of Hirudos, 22 parts of Pheretimas, 30 parts of Endothelium Corneum Gigeriae Galli, 33 parts of Rhizoma Chuanxiongs, 32 parts of Radix Salviae Miltiorrhizaes, 22 parts of Radix Notoginseng, 15 parts on Flos Carthami, 30 parts of Rhizoma Acori Graminei, 13 parts of Radix Curcumaes, 22 parts of Radix Polygalaes, 13 parts of Rhizoma Ligusticis.
Preparation method of Chinese medicine of the present invention is with embodiment 1.
Embodiment 5
Be to make in of the present invention: 50 parts of Hirudos, 27 parts of Pheretimas, 33 parts of Endothelium Corneum Gigeriae Galli, 38 parts of Rhizoma Chuanxiongs, 38 parts of Radix Salviae Miltiorrhizaes, 28 parts of Radix Notoginseng, 23 parts on Flos Carthami, 23 parts of Rhizoma Acori Graminei, 18 parts of Radix Curcumaes, 27 parts of Radix Polygalaes, 17 parts of Rhizoma Ligusticis by the component of following weight portion.
Preparation method of Chinese medicine of the present invention is with embodiment 1.
The case that Chinese medicine of the present invention is cured is exemplified below:
Zhang, the man 52 years old, suffered from hypertension 22 years, not conventional medication treatment.Cardiopalmus, pain uncomfortable in chest occur on January 15th, 2003 and go to a doctor.The time examine symptom: pain uncomfortable in chest, cardiopalmus, dizziness, sweating, weak, irritated; Have a blood test and press 180/90mmHg; Electrocardio diagram: lower wall, preceding partition myocardial ischemia; Blood fat: cholesterol 7.5ml/L.Be diagnosed as coronary heart disease, angina pectoris.Take Chinese medicinal capsule of the present invention, three times on the one, one time four, and join pained stator three times on the one, an a slice is with blood pressure lowering.Further consultation after 3 days, all diseases are taken a turn for the better, are alleviated, and blood pressure 145/85mmHg continues to take the surplus recovery from illness in February of former prescription, and all diseases are eliminated.
The king so-and-so, the woman, 63 years old, in the numb material resources of on May 8th, 2006 burst left limb, promptly go to a doctor, head CT shows: right side basal ganglia region multiple cerebral infarction.Blood fat: cholesterol 7.6ml/L, triglyceride 3.62ml/L.Diagnosis: cerebral infarction.Take Chinese medicinal capsule of the present invention, three times on the one, four first.It is surplus to take February, and all diseases are eliminated, freedom of movement, and life can be taken care of oneself, and blood fat recovers normal range, recovery from illness.
The embodiment of the invention is the non-limiting technical scheme of the present invention in order to explanation only; the dosage form that Chinese medicine of the present invention adopts can also be powder; tablet or other pharmaceutically acceptable dosage form, this is the conspicuous replacement that is equal to for those skilled in the art, all falls into protection scope of the present invention.
Claims (3)
1. Chinese medicine for the treatment of cardiovascular and cerebrovascular disease, it is characterized in that: the component that is following weight portion is made: 20～50 parts of Hirudos, 20～30 parts of Pheretimas, 25～40 parts of Endothelium Corneum Gigeriae Galli, 30～40 parts of Rhizoma Chuanxiongs, 30～40 parts of Radix Salviae Miltiorrhizaes, 20～30 parts of Radix Notoginseng, 15～30 parts on Flos Carthami, 15～30 parts of Rhizoma Acori Graminei, 10～20 parts of Radix Curcumaes, 20～30 parts of Radix Polygalaes, 10～20 parts of Rhizoma Ligusticis.
2. the Chinese medicine of treatment cardiovascular and cerebrovascular disease according to claim 1, it is characterized in that: the component that is following weight portion is made: 30～40 parts of Hirudos, 22～27 parts of Pheretimas, 30～35 parts of Endothelium Corneum Gigeriae Galli, 33～38 parts of Rhizoma Chuanxiongs, 32～38 parts of Radix Salviae Miltiorrhizaes, 22～28 parts of Radix Notoginseng, 20～25 parts on Flos Carthami, 20～26 parts of Rhizoma Acori Graminei, 13～18 parts of Radix Curcumaes, 22～27 parts of Radix Polygalaes, 13～17 parts of Rhizoma Ligusticis.
3. the Chinese medicine of treatment cardiovascular and cerebrovascular disease according to claim 1 is characterized in that: the dosage form that this Chinese medicine adopted is a capsule formulation.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN200910312176XA CN101711854B (en) | 2009-12-24 | 2009-12-24 | Traditional Chinese medicine for treating cardiovascular and cerebrovascular diseases |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN200910312176XA CN101711854B (en) | 2009-12-24 | 2009-12-24 | Traditional Chinese medicine for treating cardiovascular and cerebrovascular diseases |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101711854A CN101711854A (en) | 2010-05-26 |
| CN101711854B true CN101711854B (en) | 2011-05-04 |
Family
ID=42416101
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN200910312176XA Expired - Fee Related CN101711854B (en) | 2009-12-24 | 2009-12-24 | Traditional Chinese medicine for treating cardiovascular and cerebrovascular diseases |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101711854B (en) |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1401347A (en) * | 2001-09-07 | 2003-03-12 | 孙守贵 | Brain and heart recovery pill |
| CN1404847A (en) * | 2001-08-09 | 2003-03-26 | 项钧 | Medicine for treating sequel resulted from cardio-cerebral blood-vessel diseases |
| CN101116712A (en) * | 2007-03-26 | 2008-02-06 | 董春玲 | Drug for curing cerebral infarction --- liquid for promoting blood circulation and removing blood stasis |
-
2009
- 2009-12-24 CN CN200910312176XA patent/CN101711854B/en not_active Expired - Fee Related
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1404847A (en) * | 2001-08-09 | 2003-03-26 | 项钧 | Medicine for treating sequel resulted from cardio-cerebral blood-vessel diseases |
| CN1401347A (en) * | 2001-09-07 | 2003-03-12 | 孙守贵 | Brain and heart recovery pill |
| CN101116712A (en) * | 2007-03-26 | 2008-02-06 | 董春玲 | Drug for curing cerebral infarction --- liquid for promoting blood circulation and removing blood stasis |
Non-Patent Citations (1)
| Title |
|---|
| 刘璟洁等.脑心通对脑梗死患者血脂、血糖及纤维蛋白原水平的影响.《中国老年保健医学》.2008,第6卷(第4期), * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101711854A (en) | 2010-05-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN100382839C (en) | Chinese-medicinal composition for treating coronary heart disease | |
| CN103156972B (en) | Traditional Chinese medicine combination for treating fracture, hairline fracture and traumatic injury | |
| CN101168021B (en) | Medicine for treating cardio-cerebral disease | |
| CN104547939A (en) | Traditional Chinese medicine preparation for treating premature beat | |
| CN102114231B (en) | Medicine for treating arrhythmia | |
| CN100512852C (en) | Composite Chinese medicine took orally for treating coronary heart disease | |
| CN101112603A (en) | Cardiac and cerebral vascular disease treating medicine and method for preparing the same | |
| CN102908391B (en) | Chinese medicinal composition for treating dermatosis and preparation method and application thereof | |
| CN103919910A (en) | Medicine for treating coronary heart disease | |
| CN102784234B (en) | Traditional Chinese medicine composition for treating chronic urticaria | |
| CN104906274A (en) | Traditional Chinese medicine for treating coronary heart disease | |
| CN101711854B (en) | Traditional Chinese medicine for treating cardiovascular and cerebrovascular diseases | |
| CN103920005B (en) | Medicine is intervened before a kind of neurosurgery general anesthesia patients | |
| CN102836338A (en) | Chinese medicament for treating cardia-cerebrovascular diseases | |
| CN103212041B (en) | Chinese medicinal composition treating coronary heart disease | |
| CN103127413B (en) | Pharmaceutical preparation for treating coronary diseases | |
| CN103520289A (en) | Chinese medicinal composition for treating constipation, preparation method and application thereof | |
| CN103006998B (en) | Medicine for treating acute glomerulonephritis (AGN) hypertensive crisis | |
| CN103028088B (en) | Traditional Chinese medicine composition for treating coronary heart disease and angina | |
| CN102293891A (en) | Chinese medicine for treating cardiovascular disease and preparation method thereof | |
| CN106074784A (en) | The Chinese medicine for the treatment of coronary heart disease and myocardial ischemia | |
| CN106177422A (en) | A kind of Chinese medicine formula of warming YANG to expel cold | |
| CN100594916C (en) | Plaster for reducing the blood pressure | |
| CN106237069A (en) | A kind of Chinese medicine formula treating coronary heart disease | |
| CN101698048A (en) | Traditional Chinese medicine ointment for treating high blood pressure and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20110504 Termination date: 20141224 |
|
| EXPY | Termination of patent right or utility model |